Literature DB >> 23062566

Cardiovascular risk factors in a patient with diabetes mellitus and coronary artery disease: therapeutic approaches to improve outcomes: perspectives of a preventive cardiologist.

Michael H Davidson1.   

Abstract

In patients with diabetes mellitus (DM), a cardiovascular event is of critical concern because of the impact on long-term survival. Cardiovascular disease (CVD) is the leading cause of death for patients with DM, which makes the modification of risk factors in the patient with DM and CVD a primary focus of the preventive cardiologist. Management of this patient population should include pharmacologic interventions, such as antidyslipidemics (mainly statins) and oral anti-DM (or insulin) agents, as well as diet control, physical exercise, and smoking cessation. It is hoped that focus on the ABCs of treatment--hemoglobin A(1c), blood pressure, and cholesterol-lipid profile--along with ongoing and future studies on the effects of these interventions will help to reduce the significant morbidity and mortality from microvascular and macrovascular complications in these high-risk patients with DM.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23062566     DOI: 10.1016/j.amjcard.2012.08.033

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  15 in total

1.  Icariin prevents cytokine-induced β-cell death by inhibiting NF-κB signaling.

Authors:  Shao Zhong; Jing Ge; Jiang-Yi Yu
Journal:  Exp Ther Med       Date:  2018-07-20       Impact factor: 2.447

Review 2.  The two faces of miR-29.

Authors:  Anna Ślusarz; Lakshmi Pulakat
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2015-07       Impact factor: 2.160

Review 3.  Cardiovascular safety profile of currently available diabetic drugs.

Authors:  Komola Azimova; Zinnia San Juan; Debabrata Mukherjee
Journal:  Ochsner J       Date:  2014

4.  Effects of Lactobacillus plantarum FZU3013-Fermented Laminaria japonica on Lipid Metabolism and Gut Microbiota in Hyperlipidaemic Rats.

Authors:  Jin-Peng Hu; Ting-Ting Zheng; Bin-Fen Zeng; Man-Ling Wu; Rui Shi; Ye Zhang; Li-Jiao Chen; Wen-Jian Cheng; Peng Liang
Journal:  Front Nutr       Date:  2021-12-06

5.  The significance of circulating endothelin-1 as a predictor of coronary artery disease status and clinical outcomes following coronary artery catheterization.

Authors:  Fadia Mayyas; Mohammad Al-Jarrah; Khalid Ibrahim; Doaa Mfady; David R Van Wagoner
Journal:  Cardiovasc Pathol       Date:  2014-08-15       Impact factor: 2.185

6.  Diabetes mellitus may induce cardiovascular disease by decreasing neuroplasticity.

Authors:  Zhihua Zheng; Junyan Wu; Ruolun Wang; Yingtong Zeng
Journal:  Funct Neurol       Date:  2014 Jan-Mar

7.  Curcumin ameliorates autoimmune diabetes. Evidence in accelerated murine models of type 1 diabetes.

Authors:  C N Castro; A E Barcala Tabarrozzi; J Winnewisser; M L Gimeno; M Antunica Noguerol; A C Liberman; D A Paz; R A Dewey; M J Perone
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

8.  The impact of neuropathic pain and other comorbidities on the quality of life in patients with diabetes.

Authors:  Vesna Dermanovic Dobrota; Pero Hrabac; Dinko Skegro; Ranko Smiljanic; Savko Dobrota; Ingrid Prkacin; Neva Brkljacic; Kristijan Peros; Martina Tomic; Vesna Lukinovic-Skudar; Vanja Basic Kes
Journal:  Health Qual Life Outcomes       Date:  2014-12-03       Impact factor: 3.186

9.  Glycosylated hemoglobin A1c as a marker predicting the severity of coronary artery disease and early outcome in patients with stable angina.

Authors:  Li-Feng Hong; Xiao-Lin Li; Yuan-Lin Guo; Song-Hui Luo; Cheng-Gang Zhu; Ping Qing; Rui-Xia Xu; Na-Qiong Wu; Jian-Jun Li
Journal:  Lipids Health Dis       Date:  2014-05-29       Impact factor: 3.876

10.  Effects of treatment with liraglutide on oxidative stress and cardiac natriuretic peptide levels in patients with type 2 diabetes mellitus.

Authors:  Kenta Okada; Kazuhiko Kotani; Hiroaki Yagyu; Akihiko Ando; Jun-Ichi Osuga; Shun Ishibashi
Journal:  Endocrine       Date:  2014-04-03       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.